Skip to Content

Anjeso Dosage

Generic name: MELOXICAM 30mg in 1mL
Dosage form: injection

Medically reviewed by Last updated on Feb 17, 2020.

Use for the shortest duration consistent with individual patient treatment goals [see Warnings and Precautions (5)].

For intravenous administration only.

The recommended dose of ANJESO is 30 mg once daily, administered by intravenous bolus injection over 15 seconds.

When initiating ANJESO, monitor patient analgesic response. Because the median time to meaningful pain relief was 2 and 3 hours after ANJESO administration in two clinical studies, a non-NSAID analgesic with a rapid onset of effect may be needed, for example, upon anesthetic emergence or resolution of local or regional anesthetic blocks [see Clinical Studies (14)].

Some patients may not experience adequate analgesia for the entire 24-hour dosing interval and may require administration of a short-acting, non-NSAID, immediate-release analgesic [see Clinical Studies (14)].

To reduce the risk of renal toxicity, patients must be well hydrated prior to administration of ANJESO.

Visually inspect parenteral drug products for particulate matter and discoloration prior to administration. Should the contents appear discolored or contain particulate matter, discard the vial [see Dosage Forms and Strengths (3)].

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Related questions

More about Anjeso (meloxicam)

Consumer resources

Other brands: Mobic, Vivlodex, Qmiiz ODT

Professional resources

Related treatment guides